New‐onset autoimmune phenomena post‐COVID‐19 vaccination
Y Chen, Z Xu, P Wang, XM Li, ZW Shuai, DQ Ye… - …, 2022 - Wiley Online Library
Abstract Coronavirus disease 2019 (COVID‐19) pandemic caused by severe acute
respiratory syndrome coronavirus 2 (SARS‐CoV‐2) has led to an unprecedented setback for …
respiratory syndrome coronavirus 2 (SARS‐CoV‐2) has led to an unprecedented setback for …
[HTML][HTML] IgG4 antibodies induced by repeated vaccination may generate immune tolerance to the SARS-CoV-2 spike protein
Less than a year after the global emergence of the coronavirus SARS-CoV-2, a novel
vaccine platform based on mRNA technology was introduced to the market. Globally, around …
vaccine platform based on mRNA technology was introduced to the market. Globally, around …
[HTML][HTML] Autoantibodies and SARS-CoV2 infection: The spectrum from association to clinical implication: Report of the 15th Dresden Symposium on Autoantibodies
The relation between infections and autoimmune diseases has been extensively
investigated. Multiple studies suggest a causal relation between these two entities with …
investigated. Multiple studies suggest a causal relation between these two entities with …
Adverse events following COVID‐19 mRNA vaccines: A systematic review of cardiovascular complication, thrombosis, and thrombocytopenia
Abstract Background and Objectives Since publishing successful clinical trial results of
mRNA coronavirus disease 2019 (COVID‐19) vaccines in December 2020, multiple reports …
mRNA coronavirus disease 2019 (COVID‐19) vaccines in December 2020, multiple reports …
COVID-19 vaccines adverse events: potential molecular mechanisms
M Lamprinou, A Sachinidis, E Stamoula, T Vavilis… - Immunologic …, 2023 - Springer
COVID-19 is an infectious disease caused by a single-stranded RNA (ssRNA) virus, known
as SARS-CoV-2. The disease, since its first outbreak in Wuhan, China, in December 2019 …
as SARS-CoV-2. The disease, since its first outbreak in Wuhan, China, in December 2019 …
Melatonin: highlighting its use as a potential treatment for SARS-CoV-2 infection
Numerous pharmaceutical drugs have been repurposed for use as treatments for COVID-19
disease. These drugs have not consistently demonstrated high efficacy in preventing or …
disease. These drugs have not consistently demonstrated high efficacy in preventing or …
Understanding the concept of pre-clinical autoimmunity: prediction and prevention of systemic lupus erythematosus: identifying risk factors and develo** strategies …
MY Choi, KH Costenbader - Frontiers in immunology, 2022 - frontiersin.org
There is growing evidence that preceding the diagnosis or classification of systemic lupus
erythematosus (SLE), patients undergo a preclinical phase of disease where markers of …
erythematosus (SLE), patients undergo a preclinical phase of disease where markers of …
Autoimmune hepatitis after COVID-19 vaccination
H Zheng, T Zhang, Y Xu, X Lu, X Sang - Frontiers in Immunology, 2022 - frontiersin.org
Vaccination is one of the most vigorous ways to intervene in the severe acute respiratory
syndrome coronavirus 2 (SARS-CoV-2) pandemic. Cases of autoimmune hepatitis (AIH) …
syndrome coronavirus 2 (SARS-CoV-2) pandemic. Cases of autoimmune hepatitis (AIH) …
COVID-19, vaccines, and thrombotic events: a narrative review
The coronavirus disease 2019 (COVID-19), a deadly pandemic that has affected millions of
people worldwide, is associated with cardiovascular complications, including venous and …
people worldwide, is associated with cardiovascular complications, including venous and …
Emergence of post COVID-19 vaccine autoimmune diseases: a single center study
Introduction Severe acute respiratory syndrome coronavirus 2 (SARS CoV-2) became a
major concern since the announcement that it is a pandemic in early 2020. Vaccine trials …
major concern since the announcement that it is a pandemic in early 2020. Vaccine trials …